Cellromax Science Co Ltd
471820
Company Profile
Business description
Cellromax Science Co Ltd is engaged in product development and distribution in the health-functional food market using pharmacies and online B2C e-commerce platforms and also develops various products in the general pharmaceutical and cosmetics sectors every year. Its products include Health functional food, Cosmetics, and General medicine.
Contact
357 Guseong-ro
Yongin Techno Valley, Building D, Room 710
Giheung-gu
Gyeonggi-do
Yongin-si
KORT: +82 316621395
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2025
Employees
53
Stocks News & Analysis
stocks
Lower fair value for undervalued ASX share
Despite our lower fair value the shares are still attractive.
stocks
Unconventional wisdom: Should I sell this underperforming ASX share?
Going back to my original thesis to evaluate a position.
stocks
Wildly overvalued ASX stock is skating on thin ice
This company dominates its industry and could be flirting with regulatory intervention.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,076.60 | 25.40 | -0.28% |
| CAC 40 | 7,743.00 | 33.68 | 0.44% |
| DAX 40 | 24,162.86 | 29.64 | -0.12% |
| Dow JONES (US) | 44,175.61 | 206.97 | 0.47% |
| FTSE 100 | 9,095.73 | 5.04 | -0.06% |
| HKSE | 24,858.82 | 222.81 | -0.89% |
| NASDAQ | 21,450.02 | 207.32 | 0.98% |
| Nikkei 225 | 41,820.48 | 761.33 | 1.85% |
| NZX 50 Index | 12,844.63 | 42.47 | -0.33% |
| S&P 500 | 6,389.45 | 49.45 | 0.78% |
| S&P/ASX 200 | 8,807.10 | 24.30 | -0.28% |
| SSE Composite Index | 3,635.13 | 4.54 | -0.12% |